
Morgan Stanley maintains Microchip at Overweight, PT $97.00
A Morgan Stanley analyst maintained Microchip (NASDAQ: MCHP) at Overweight and a price target of $97.00 from a prior price target of $99.00. Prior to this rating, Microchip had 16 buy...
A Morgan Stanley analyst maintained Microchip (NASDAQ: MCHP) at Overweight and a price target of $97.00 from a prior price target of $99.00. Prior to this rating, Microchip had 16 buy...
A KeyBanc analyst maintained Microchip (NASDAQ: MCHP) at Overweight and a price target of $95.00 from a prior price target of $100.00. Prior to this rating, Microchip had 16 buy ratings,...
Investing.com - U.S. stock futures were trading higher during Thursday's evening trade after benchmark indices declined for the fourth consecutive session amid continuing banking stresses,...
After-Hours Stock Movers: Trupanion Inc (NASDAQ:TRUP) 27% LOWER; {{erl-940816||reported Q1 EPS of ($0.60), $0.33 worse than the analyst estimate of ($0.27). Revenue for the quarter came in...
Investing.com - Microchip (NASDAQ: MCHP) reported fourth quarter EPS of $1.64, $0.02 better than the analyst estimate of $1.62. Revenue for the quarter came in at $2.23B versus the consensus...
Microchip Technology (NASDAQ:MCHP) declared a quarterly dividend of $0.383 per share, or $1.532 annualized.The dividend will be payable on June 5, 2023, to stockholders of record on May 22,...
Here is your VIP list of Pro Picks, offered exclusively to InvestingPro subscribers: a hand-picked selection of S&P 500 stocks that InvestingPro awarded a high financial health score...
A Susquehanna analyst maintained Microchip (NASDAQ: MCHP) at Positive and a price target of $95.00 from a prior price target of $100.00. Prior to this rating, Microchip had 16 buy...
Microchip Technology (NASDAQ:MCHP) Inc. (Nasdaq: MCHP) – a leading provider of smart, connected and secure embedded control solutions – has reached a milestone in its multi-year, $800...
By Senad Karaahmetovic Citi analysts remain bearish on semi stocks and believe the additional earnings estimates cuts are coming. They were some of the first sell-side analysts to call for a...
Investing.com - Microchip (NASDAQ: MCHP) reported third quarter EPS of $1.56, $0.01 better than the analyst estimate of $1.55. Revenue for the quarter came in at $2.17B versus the consensus...
Microchip Technology (MCHP) reported Q3 EPS of $1.56, $0.01 better than the analyst estimate of $1.55. Revenue for the quarter came in at $2.17 billion versus the consensus estimate of $2.16...
By Senad Karaahmetovic Morgan Stanley analysts promoted Advanced Micro Devices (NASDAQ:AMD) stock to top chip stock to own in 2023, replacing Lam Research (NASDAQ:LRCX). The analysts...
By Sam Boughedda BofA analysts said in a note Tuesday that the firm's U.S. Semiconductors survey shows investors in the industry are less bullish than in 2020 and 2021. Over the last week,...
Microchip Technology (MCHP) reported Q2 EPS of $1.46, $0.02 better than the analyst estimate of $1.44. Revenue for the quarter came in at $2.07 billion versus the consensus estimate of $2.06...
By Investing.com Staff Stocks continued to grind higher today on continued hopes that the Fed will soon start to slow interest rate increases. Amid the gains, several rumors swirled around...
By Senad Karaahmetovic Citi analysts cut estimates on semi stocks after the latest round of checks indicated delays and cancellations, which Analog Devices (NASDAQ:ADI) warned about in...
(Bloomberg) -- Nvidia (NASDAQ:NVDA) is one of the worst-performing semiconductor stocks this year, though the shares are hardly in the bargain basement bin. After a 42% drop, the maker of...
Microchip Technology (NASDAQ:MCHP) reported Q1 EPS of $1.37, $0.04 better than the analyst estimate of $1.33. Revenue for the quarter came in at $1.96 billion versus the consensus estimate...
By Sam Boughedda Microchip Technology (NASDAQ:MCHP) was upgraded from Hold to Buy, and its price target was raised to $75 from $70 by Stifel analyst Tore Svanberg on Tuesday. The analyst...
Pre-Open Stock Movers: Kezar Life Sciences , Inc. (Nasdaq: NASDAQ:KZR) 90% HIGHER; reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib, a...
By Sam Boughedda Morgan Stanley analyst Joseph Moore cut the price targets of several semiconductor names Friday, telling investors in a note that they are lowering their 2023 numbers. The...
(Bloomberg) -- After this year’s steep declines for US information technology stocks, Jefferies Group LLC strategists have turned bullish on the likes of IBM (NYSE:IBM), Cisco Systems...
Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Technology, Oil & Gas and Healthcare sectors propelled shares higher while losses in the Utilities,...
Pre-Open Stock Movers:Biohaven Pharmaceutical (BHVN) 71% HIGHER; Pfizer Inc. (NYSE:PFE) and Biohaven Pharmaceutical Holding Company Ltd. (BHVN) today announced that the companies have...
By Oliver Gray Investing.com - Dow futures were trading slightly higher during Monday’s evening deals, after major benchmark indices declined steeply during regular trade, with the S&P 500...
Microchip Technology (NASDAQ:MCHP) shares were trading more than 3% higher after-hours following the company’s reported {{erl-6391||Q4 results, with EPS of $1.35 coming in better than the...
Microchip Technology (NASDAQ:MCHP) reported Q4 EPS of $1.35, $0.10 better than the analyst estimate of $1.25. Revenue for the quarter came in at $1.84 billion versus the consensus estimate...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.